Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialÉtienne Garin, Hélène Regnault, Karim Boudjéma et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 602
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapyFrancesco Ceci, Désirèe Deandreis, Guido Rovera et al.|European Journal of Nuclear Medicine and Molecular Imaging|2022Cited by 26
Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot StudyGuido Rovera, Désirèe Deandreis, Séréna Grimaldi et al.|Diagnostics|2023Cited by 12
Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Silvia Morbelli, Séréna Grimaldi et al.|Diagnostics|2024Cited by 12
Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or PersistenceGuido Rovera, Désirèe Deandreis, Séréna Grimaldi et al.|Diagnostics|2022Cited by 7